Risk stratification in heart failure decompensation in the community: HEFESTOS score
ESC Heart Failure Nov 26, 2021
Verdu-Rotellar JM, Abellana R, Vaillant-Roussel H, et al. - Based on variables easily accessible in a community setting, the HEFESTOS score was developed in this study as well as validated in an external European cohort. This score enabled proper prediction of the risk of death/hospitalization during the first 30 days following a heart failure (HF) decompensation episode.
In this multinational study (HEFESTOS), a derivation cohort comprising HF patients recruited in 14 primary healthcare centers in Barcelona as well as a validation cohort from primary healthcare in 9 other European countries were included.
In the derivation and validation cohorts, there were 561 and 250 patients, respectively, and mortality/hospitalization during the first 30 days after a decompensation episode was 30.5% and 26%, respectively.
A score of risk was created using multivariable logistic regression models, and identified predictors included worsening of dyspnea, orthopnea, paroxysmal nocturnal dyspnea, crackles, New York Heart Association functional class III/IV, oxygen saturation ≤ 90%, heart rate > 100 b.p.m., and previous hospitalization due to HF.
In the derivation and validation cohorts, an area under the curve of 0.807 and 0.73, respectively, was generated by the model.
With respect to the likelihood of hospitalization/death, three risk groups were described: low <5%, medium 5–20%, and high >20%.
In the derivation cohort, outcome incidence for the low-risk, medium risk, and high risk groups was 2.7%, 12.8%, and 46.2%, respectively; in the validation cohort, it was 9.1%, 12.9%, and 39.6%.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries